Upadacitinib Versus Tofacitinib in UC; Etrasimod for Proctitis

Miguel Regueiro, MD

Professor of Medicine
Chief of the Digestive Disease Institute
Cleveland Clinic, Cleveland

Prospective studies that directly compare the efficacy of two different medications remain rare in our field, although they do exist and should become more common in future years. Although such studies are ideal for guiding treatment decisions, well-designed retrospective studies that compare the benefits of two medications are also helpful.

The